Chen Y L, Wu R T
Graduate Institute of Microbiology and Immunology, National Yang-Ming Medical College, Taipei, Republic of China.
Cancer Res. 1994 Apr 15;54(8):2192-8.
Altered queuine modification of tRNA has been correlated to neoplasia and cell differentiation, but much of the existing evidence is only circumstantial. In the present study, we used several distinct differentiation inducers to measure changes in Q-family tRNA species during the erythroid differentiation of human K562 erythroleukemia cells. Treatment of K562 cells with 3.6 microM 1-beta-D-arabinofuranosylcytosine (ara-C), 1 mM sodium butyrate, 0.1 mM hemin, or 5 microM 5-azacytidine resulted in growth inhibition, erythroid differentiation, and changes in queuine content of tRNA. In the presence of the irreversible inducer ara-C, the queuine content of tRNA increased markedly when the cells differentiated into benzidine-positive erythroid cells, and cell growth was inhibited. The increase in the queuine content of tRNA in differentiated K562 cells was an irreversible event. In cells incubated with the reversible inducer sodium butyrate, an increase in the queuine content of tRNA was correlated with the increase in benzidine-positive erythroid cells throughout the culturing period. After removal of the drug at 48 h, the queuine content of tRNA decreased concomitant with a decrease in benzidine-positive cells. Treatment with another reversible inducer, hemin, caused only a transient increase in the queuine content of tRNA, which was not correlated with the steady increase in benzidine-positive erythroid cells. The agent 5-azacytidine slightly inhibited cell growth but did not significantly change the percentage of benzidine-positive cells and the queuine content of tRNA. We further clarified the changes in queuine content of tRNA by analyzing the Q-containing isoacceptors of Q-family tRNA species including tRNA(Tyr), tRNA(His), tRNA(Asp), and tRNA(Asn) by RPC-5 chromatography, and found that the change in queuine content of tRNA(Tyr) was greater than the other Q-family tRNA species during induction by ara-C, sodium butyrate, and hemin. Our results indicate that the change in queuine content of tRNA is an irreversible event of terminal differentiation in ara-C induction and is a transient event of reversible differentiation in hemin induction. Sodium butyrate induction might represent a status between irreversible and reversible differentiation. Q-containing isoacceptors of tRNA might potentially play an important biological role during K562 cell differentiation.
tRNA中异戊烯基修饰的改变已与肿瘤形成和细胞分化相关,但现有证据大多只是间接的。在本研究中,我们使用了几种不同的分化诱导剂来测量人K562红白血病细胞红系分化过程中Q家族tRNA种类的变化。用3.6微摩尔/升的1-β-D-阿拉伯呋喃糖基胞嘧啶(ara-C)、1毫摩尔/升的丁酸钠、0.1毫摩尔/升的血红素或5微摩尔/升的5-氮杂胞苷处理K562细胞,导致细胞生长受到抑制、红系分化以及tRNA中异戊烯基含量的变化。在不可逆诱导剂ara-C存在的情况下,当细胞分化为联苯胺阳性红系细胞时,tRNA中的异戊烯基含量显著增加,且细胞生长受到抑制。分化的K562细胞中tRNA异戊烯基含量的增加是一个不可逆的事件。在用可逆诱导剂丁酸钠孵育的细胞中,在整个培养期间,tRNA异戊烯基含量的增加与联苯胺阳性红系细胞的增加相关。在48小时去除药物后,tRNA的异戊烯基含量随着联苯胺阳性细胞的减少而降低。用另一种可逆诱导剂血红素处理仅导致tRNA异戊烯基含量短暂增加,这与联苯胺阳性红系细胞的稳定增加无关。5-氮杂胞苷略微抑制细胞生长,但对联苯胺阳性细胞的百分比和tRNA的异戊烯基含量没有显著影响。我们通过RPC-5色谱法分析包括tRNA(Tyr)、tRNA(His)、tRNA(Asp)和tRNA(Asn)在内的Q家族tRNA种类的含Q同功受体,进一步阐明了tRNA异戊烯基含量的变化,发现在ara-C、丁酸钠和血红素诱导过程中,tRNA(Tyr)的异戊烯基含量变化大于其他Q家族tRNA种类。我们的结果表明,在ara-C诱导中,tRNA异戊烯基含量的变化是终末分化的不可逆事件,而在血红素诱导中是可逆分化的短暂事件。丁酸钠诱导可能代表一种介于不可逆和可逆分化之间的状态。tRNA的含Q同功受体在K562细胞分化过程中可能发挥重要的生物学作用。